RevMedx announces adoption of XSTAT® gunshot wound treatment by emergency responders in Highland Park, Texas

RevMedX XSTAT gunshot wound treatment adopted by Highland Park Texas emergency responders. FDA-cleared hemostatic device for trauma care and hemorrhage control.

FDA clears XSTAT for the treatment of severe bleeding from gunshot and stab wounds to the arms or legs

RevMedx™ Announces FDA clearance of XSTAT® 12

RevMedx™ Announces First Product Shipments of XSTAT™ to US Military.

WILSONVILLE, Ore., April 16, 2015 /PRNewswire-iReach/ -- RevMedx, Inc. today announced the company's first shipment of its XSTAT™ hemorrhage control device to the US Military. This shipment marks the first...

RevMedx receives FDA clearance for XStat™ device

RevMedx wins MEDY award at FutureMed 2013

RevMedx’s XSTAT™ dressing was recognized with a MEDY award for the most disruptive technology at FutureMed November 2013 (Hotel Del Coronado, San Diego, California.) FutureMed is a specialized executive program...

Panakeia, LLC adds RevMedx, Inc. AirWrap™ to its Critical Care and Advanced Life Support Line of Products

Fayetteville, North Carolina and Stafford, Virginia (August 30, 2013) – Panakeia, LLC, which distributes healthcare solutions to the Military Health System, announced today it has entered into a distribution agreement...

Oregon Health and Science University and RevMedx Inc. awarded seed grant by “Saving Lives at Birth” Grand Challenge

Oregon Health and Science University (OHSU) and RevMedx Inc. won a USAID/Gates-sponsored seed grant to develop a novel treatment for postpartum hemorrhage based on RevMedx’s XSTAT™ technology. The OHSU/RevMedx proposal...